Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-004113

Chief Scientific Officer sold 11,100 shares at an average $28.77 ($319,329)

  • Chief Scientific Officer acquired 11,100 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-01-15 Option exercise +3,700 $6.32 $23,384 74,379 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-15 Sale −3,700 $29.52 $109,224 70,679 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-16 Option exercise +3,700 $6.32 $23,384 74,379 D: show line 3 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-16 Sale −1,100 $27.80 $30,580 73,279 D: show line 4 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-16 Sale −1,300 $28.98 $37,674 71,979 D: show line 5 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-16 Sale −1,300 $29.54 $38,402 70,679 D: show line 6 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-17 Option exercise +3,700 $6.32 $23,384 74,379 D: show line 7 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-17 Sale −1,300 $27.33 $35,529 73,079 D: show line 8 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-17 Sale −2,400 $28.30 $67,920 70,679 D: show line 9 in the form
Open-market sales · 11,100 sh · avg $28.77 · $319,329

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-01-15 Option exercise · Stock Option (Right to Buy) −3,700 596,300 D: show line 10 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-16 Option exercise · Stock Option (Right to Buy) −3,700 592,600 D: show line 11 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-01-17 Option exercise · Stock Option (Right to Buy) −3,700 588,900 D: show line 12 in the form
Loading xslF345X03/doc4.xml…